These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 12195191

  • 1. Diagnostic role of anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease.
    Kim BG, Kim YS, Kim JS, Jung HC, Song IS.
    Dis Colon Rectum; 2002 Aug; 45(8):1062-9. PubMed ID: 12195191
    [Abstract] [Full Text] [Related]

  • 2. Antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies in inflammatory bowel diseases.
    Kiliç ZM, Tunç B, Ayaz S, Filik L, Aktaş S, Parlak E, Ulker A.
    Turk J Gastroenterol; 2004 Dec; 15(4):238-42. PubMed ID: 16249978
    [Abstract] [Full Text] [Related]

  • 3. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.
    Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, Charrier G, Targan SR, Colombel JF, Poulain D.
    Gut; 1998 Jun; 42(6):788-91. PubMed ID: 9691915
    [Abstract] [Full Text] [Related]

  • 4. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
    Annese V, Piepoli A, Perri F, Lombardi G, Latiano A, Napolitano G, Corritore G, Vandewalle P, Poulain D, Colombel JF, Andriulli A.
    Aliment Pharmacol Ther; 2004 Nov 15; 20(10):1143-52. PubMed ID: 15569117
    [Abstract] [Full Text] [Related]

  • 5. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease.
    Koutroubakis IE, Petinaki E, Mouzas IA, Vlachonikolis IG, Anagnostopoulou E, Castanas E, Maniatis AN, Kouroumalis EA.
    Am J Gastroenterol; 2001 Feb 15; 96(2):449-54. PubMed ID: 11232689
    [Abstract] [Full Text] [Related]

  • 6. Serological differentiation of inflammatory bowel diseases.
    Conrad K, Schmechta H, Klafki A, Lobeck G, Uhlig HH, Gerdi S, Henker J.
    Eur J Gastroenterol Hepatol; 2002 Feb 15; 14(2):129-35. PubMed ID: 11981336
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases.
    Saibeni S, Folli C, de Franchis R, Borsi G, Vecchi M.
    Dig Liver Dis; 2003 Dec 15; 35(12):862-8. PubMed ID: 14703881
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
    Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P.
    Am J Gastroenterol; 2001 Mar 15; 96(3):730-4. PubMed ID: 11280542
    [Abstract] [Full Text] [Related]

  • 9. Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil cytoplasmic antibodies in coeliac disease before and after gluten-free diet.
    Granito A, Zauli D, Muratori P, Muratori L, Grassi A, Bortolotti R, Petrolini N, Veronesi L, Gionchetti P, Bianchi FB, Volta U.
    Aliment Pharmacol Ther; 2005 Apr 01; 21(7):881-7. PubMed ID: 15801923
    [Abstract] [Full Text] [Related]

  • 10. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment.
    Oudkerk Pool M, Ellerbroek PM, Ridwan BU, Goldschmeding R, von Blomberg BM, Peña AS, Dolman KM, Bril H, Dekker W, Nauta JJ.
    Gut; 1993 Jan 01; 34(1):46-50. PubMed ID: 8432451
    [Abstract] [Full Text] [Related]

  • 11. Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies as serological markers are not specific in the identification of Crohn's disease and ulcerative colitis.
    Anand V, Russell AS, Tsuyuki R, Fedorak R.
    Can J Gastroenterol; 2008 Jan 01; 22(1):33-6. PubMed ID: 18209778
    [Abstract] [Full Text] [Related]

  • 12. Update on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: results of a multicenter study.
    Desplat-Jégo S, Johanet C, Escande A, Goetz J, Fabien N, Olsson N, Ballot E, Sarles J, Baudon JJ, Grimaud JC, Veyrac M, Chamouard P, Humbel RL.
    World J Gastroenterol; 2007 Apr 28; 13(16):2312-8. PubMed ID: 17511029
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic value of antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibody in Iranian patients with inflammatory bowel disease.
    Bahari A, Aarabi M, Aarabi M, Hedayati M, Jarollahi A, Firouzi F, Aghazadeh R, Zali MR, Hashemi M.
    Acta Gastroenterol Belg; 2009 Apr 28; 72(3):301-5. PubMed ID: 19902862
    [Abstract] [Full Text] [Related]

  • 14. Antineutrophil cytoplasmic antibodies in inflammatory bowel disease: clinical role and review of the literature.
    Lombardi G, Annese V, Piepoli A, Bovio P, Latiano A, Napolitano G, Perri F, Conoscitore P, Andriulli A.
    Dis Colon Rectum; 2000 Jul 28; 43(7):999-1007. PubMed ID: 10910250
    [Abstract] [Full Text] [Related]

  • 15. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
    Mokrowiecka A, Gasiorowska A, Małecka-Panas E.
    Pol Merkur Lekarski; 2004 Jul 28; 17 Suppl 1():22-6. PubMed ID: 15603341
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease.
    Sandborn WJ, Loftus EV, Colombel JF, Fleming KA, Seibold F, Homburger HA, Sendid B, Chapman RW, Tremaine WJ, Kaul DK, Wallace J, Harmsen WS, Zinsmeister AR, Targan SR.
    Inflamm Bowel Dis; 2001 Aug 28; 7(3):192-201. PubMed ID: 11515844
    [Abstract] [Full Text] [Related]

  • 17. Serological markers (anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic antibodies) in inflammatory bowel disease: diagnostic utility and phenotypic correlation.
    Buckland MS, Mylonaki M, Rampton D, Longhurst HJ.
    Clin Diagn Lab Immunol; 2005 Nov 28; 12(11):1328-30. PubMed ID: 16275949
    [Abstract] [Full Text] [Related]

  • 18. Serologic responses in indeterminate colitis patients before ileal pouch-anal anastomosis may determine those at risk for continuous pouch inflammation.
    Hui T, Landers C, Vasiliauskas E, Abreu M, Dubinsky M, Papadakis KA, Price J, Lin YC, Huiying Y, Targan S, Fleshner P.
    Dis Colon Rectum; 2005 Jun 28; 48(6):1254-62. PubMed ID: 15868228
    [Abstract] [Full Text] [Related]

  • 19. Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Prevalence and diagnostic role.
    Hertervig E, Wieslander J, Johansson C, Wiik A, Nilsson A.
    Scand J Gastroenterol; 1995 Jul 28; 30(7):693-8. PubMed ID: 7481534
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of serological markers to differentiate between ulcerative colitis and Crohn's disease: pANCA, ASCA and agglutinating antibodies to anaerobic coccoid rods.
    Linskens RK, Mallant-Hent RC, Groothuismink ZM, Bakker-Jonges LE, van de Merwe JP, Hooijkaas H, von Blomberg BM, Meuwissen SG.
    Eur J Gastroenterol Hepatol; 2002 Sep 28; 14(9):1013-8. PubMed ID: 12352222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.